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(57) ABSTRACT 
Disclosed is a method and the resulting product thereof 
comprising a solid light-conducting fiber with a point of 
attachment and having a textured surface site consisting a 
textured distal end prepared by being placed in a vacuum 
and then subjected to directed hyperthermal beams compris- 
ing oxygen ions or atoms. The textured distal end comprises 
cones or pillars that are spaced upon from each other by less 
than 1 micron and are extremely suitable to prevent cellular 
components of blood from entering the valleys between the 
cones or pillars so as to effectively separate the cellular 
components in the blood from interfering with optical sens- 
ing of the glucose concentration for diabetic patients. 
10 Claims, 6 Drawing Sheets 
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METHOD FOR TEXTURING SURFACES OF 
OPTICAL FIBER SENSORS USED FOR 
BLOOD GLUCOSE MONITORING 
CROSS REFERENCE TO RELATED 
APPLICATIONS 
small blood droplet, for instance, a droplet having a volume 
of one (1) to five (5) microliters, or preferably 1 to 2.5 
microliters. The '937 patent allows for a reduction relative 
to the prior art thereof, of about one-fifth to about one-tenth 
of the fluid volume necessary blood glucose sensing. It is 
desired that further improvements to the surface area be 
provided, so as to correspondingly reduce the amount of 
blood necessary for determination of glucose for diabetics. 
means, such as ion beam sputtering, plasma etching includ- 
ing atomic oxygen plasma, physical abrasion, chemical 
etching, sputtering or ablation by high energy beams, or 
deposition of dendritic-like structures thereon. The textured 
surface of the '937 patent is intended to provide a means for 
separating cellular components in blood from the plasma of 
Of the United States and may be used by Or for 15 the blood so as to allow optical sensing of the glucose 
the for governmental purposes pay- concentration in the blood. The processes described in the 
ment of any royalties thereon or therefor. '937 patent for developing the textured surface need to 
produce a cone or pillar structure at the ends of optical fibers 
or other sensing surfaces which are sufficiently close-so as 
20 to prevent the cellular components from entering the micro- 
The Present invention relates to a sensing device for scopic valleys between the cones or pillars so that optical 
determination of compounds in fluids, and more Particularly, sensing of the glucose concentration can be performed. Also, 
to a solid light-conducting fiber comprising the sensing it is desired to have a sufficiently high aspect ratio (height to 
device with a point of attachment and having a textured width) of cones or pillars to allow sufficient surface area for 
surface consisting of a distal end prepared by being placed 25 optical determination of the glucose concentration in the 
in a vacuum system and then subjected to directed hyper- blood. 
thermal beams comprising oxygen ions or atoms. In pursuit for finding desired pillar structures for the 
textured surfaces, some of the different processes mentioned 
BACKGROUND OF THE INVENTION in the '937 patent were investigated and may be further 
30 described with reference to FIG. 1 herein, which illustrates 
a Scanning Electron Microscope image of the end of a 
polymethylmethacrylate optical fiber that was textured by 
the use ofthermal energy ( ~ 0 . 5  e v )  atomic oxygen though 
salt dust for enhancing texturing, 
The disadvantages of prior art shown in FIG, 1 is 
This application is a divisional application of parent 
Ser, No, 101942,637 which was filed on Sep, 16, 2004 now The '937 Patent provides a textured surface using 
abandoned. 10 . 
ORIGIN OF THE INVENTION 
The invention described herein was made by an employee 
FIELD OF THE INVENTION 
The quantification of chemical and biochemical compo- 
nents in aqueous fluids, and particularly in biological fluids 
such as whole blood or urine and in biological fluid deriva- 
tives such as serum and plasma, is of ever increasing 
importance. Important applications exist in medical diagno- 35 
and treatment and in the quantification Of exposure to 
and the 
that the craters produced were too wide to prevent cellular 
blood components from entering the optical sensing therapeutic drugs, intoxicants, hazardous like. These applications include the detection and quantifi- and the aspect ratio (height to width) of the surface features cation of an increasing variety of certain circulating anti- does not offer high gains in surface area relative to flat bodies, cancer-related metabolites, genetically derived 
chemical tracers, and hormones emitted during events such 40 surfaces. As can be seen in FIG. 1, the cone or crater ridges 
being determined are minuscule in the range ofa  microgram achieve their desired goals. More particularly, the spacing 
or less per deciliter. between cones or ridges needs to be 5 5 microns to block the 
one Cornon medical test is the measurement of blood entry of blood cells into the cone valleys. Thus, the craters 
glucose levels by diabetics which is more fully described in 45 did not provide separation of the plasma from the blood in 
U.S. pat, No. 5,859,937 ('937) of H. N0mui-a and herein the areas of the valleys between the cones or pillars where 
incorporated by reference. Portions of the teachings of the optical sensing of the glucose concentration needs to occur. 
'937 patent are used herein for the sake of completeness. The Use of thermal energy (c0.5 eV) atomic oxygen, sometimes 
glucose determination, as described in the '937 patent, referred to as isotropic thermal energy, to texture the sur- 
typically entails the diabetic piercing the skin of his or her 50 faces of clear polymers such as polymethylmethacrylate, 
finger with a lance, followed by squeezing or expression of polystyrene or other hydrocarbon polymer (even with the 
a blood droplet. The blood droplet is then transferred to a use of small particle salt shielding) causes wide almost 
reagent Pad Or test Strip. The amount of blood that is hemispherical craters to form surface features which are 
Conveniently expressed from a finger Prick is governed by only as high as they are wide. The aspect ratio of only 
the size and depth of penetration of the lance. Too small a 55 approximate~y one (1) requires greater volume blood 
intended analysis. Conversely, too deep a nick results in an optical used for blood testing be provided that 
procedure, and the degree of pain is associated with the size by less than 5 microns, preferably about 1 micron, and and depth of penetration of the lance. 
The teachings of the ,937 patent provides a textured site 60 having an aspect ratio (height to width) of greater than one 
allowing for an increased surface area, compared to other (l). 
prior art devices, for use in blood sampling. The increased 
surface area provides an advantage relating to minimizing 
the invasive feature of glucose testing because the surface 
area being very small, greatly reduces the level of analyte- 65 
responsive needed to be deposited to perform the glucose 
determination. Increased surface area allows one to utilize a 
as pregnancy, In many instances, the amounts of materials are approximately 20-30 microns apart far too much to 
nick in an sized for the samples than desirable, It is desired that textured surfaces for 
oversized Pain is experienced in the lancing provide or pillars that are spaced apart from each other 
OBJECTS OF THE INVENTION 
It is a primary object of the present invention to provide 
a process that creates a sensor having a textured surface 
comprising cones or pillars that are spaced apart from each 
US 7,308,164 B1 
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other by less than 5 microns, preferably about 1 micron, and 
having an aspect ratio of greater than one (1). 
Moreover, it is an object of the present invention to 
provide a process for making fine texture, high aspect ratio 
cone surface at the distal end of a solid light-conducting fiber 
that is necessary for optical fiber blood glucose monitoring 
with small blood samples. 
It is a further object of the present invention to provide for 
an optical sensor having cones or pillars that are sufficiently 
close so as to prevent cellular blood components for inter- 
fering with optical sensing of the blood glucose concentra- 
tion. 
Still further, it is an object of the present invention to 
provide a process that creates a textured surface for an 
optical sensing device which has a high surface area that 
correspondingly allows for a reduction in the amount of 
blood needed to be removed from a patient so as to reduce 
the pain to which the patient needs to be subjected for 
glucose determination. 
It is a further object of the present invention to provide for 
optical polymer devices serving the sensors that may be used 
for blood plasma diagnostics that require economic separa- 
tion of plasma in the whole blood for optical sensing 
measurements . 
SUMMARY OF THE INVENTION 
The present invention provides for a process that produces 
a solid light-conducting fiber with a point of attachment and 
having a distal end possessing a fine texture, high aspect 
ratio cone surface that provides for optical fiber blood 
glucose monitoring with small blood samples. 
The textured distal end of the solid light-conducting fiber 
is prepared by being placed in a vacuum and then subjected 
to direct hyperthermal beams comprising oxygen ions or 
atoms. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 illustrates a prior art Scanning Electron Micro- 
scope image of the end of an optical fiber that was textured 
by the use of thermal energy ( ~ 0 . 5  eV) atomic oxygen 
through salt dust to enhance texturing; 
FIG. 2 is a prior art schematic view of fibers with textured 
surface sites; 
FIG. 3 is a prior art schematic view of a cone field within 
a textured surface of an optic fiber; 
FIG. 4 is a prior art cross-section of a cone field with the 
deposited reagent, along with adjacent erythrocyte; 
FIG. 5 is a block diagram of a process that provides 
hypothermal ionic or atomic oxygen texturing of optical 
surfaces; 
FIG. 6 is an enlarged view of the cones or pillars of the 
textured surfaces provided by the embodiment of FIG. 5; 
FIG. 7 is a block diagram of the apparatus that provides 
the desired process of the present invention; and 
FIG. 8 is a Scanning Electron Microscope image of an 
atomic oxygen textured optical fiber of the present invention 
that was textured by means of End Hall atomic or ionic 
oxygen sources which produced hyperthermal (>1 eV) 
atomic oxygen ions. 
DETAILED DESCRIPTION OF THE 
PREFERRED EMBODIMENTS 
One of the purposes of the present invention is to create 
a surface on optically transparent polymers which has 
4 
closely spaced cones or pillars so as to prevent blood cellular 
components during optical monitoring from entering the 
valleys between the cones or pillars, which would otherwise 
interfere with the optical sensing of blood glucose concen- 
5 tration. It is also a purpose of the present invention to 
produce a high surface area of high aspect-ratio cones or 
pillars which are taller than they are wide so as to enable 
glucose sensing with a minimum volume of blood. The 
cellular components in blood predominantly consist of red 
10 blood cells (erythrocytes of 6.6-7.5 microns diameter) and 
white blood cells (leukocytes such lymphocytes of 8-10 
microns diameter, neutrophils of 12- 15 microns diameter, 
eosinophils of 12-15 microns diameter, basophils of 9-10 
microns diameter and monocytes of 16-20 microns diam- 
15 eter). Thus, a 5 micron average spacing between cones or 
pillars would serve to prevent the cellular components of 
blood from entering the valleys between the cones and 
pillars which needs to be occupied by the plasma only so as 
to prevent optical obstruction of the glucose sensing by light 
20 emitted from the sides of the cones on the textured optical 
fiber end in a manner to be described hereinafter. A further 
enhancement is provided by having the spacing between 
cones or pillars be about 1 micron. A high aspect ratio of the 
texture (cone height to cone separation) provides a greater 
25 surface area, thus enabling a smaller volume blood needed 
to measure glucose concentration. The invention may be 
further described with reference to prior art shown in FIG. 
2. 
FIG. 2 illustrates two solid light-conducting fibers 10, and 
30 12 each being transparent, each having a point of attachment 
14, and each preferably comprised of a polymer material, 
except for silicone. Each of the fibers 10, and 12 has a 
textured surface 16 at the distal end thereof that is provided 
by one of the processes of the present invention to be further 
In one application, at least one end, that is point of 
attachment 14, of the light-conductive fibers 10 or 12, is 
placed adjacent to a light source (not shown) for sending a 
4o beam of light 18 down the fiber length. The point of 
attachment 14 of each of the fibers 10 and 12 is also located 
adjacent to a device for measuring light beam characteristics 
of light 20 or 22 emanating from the fibers 10 or 12, 
respectively after being reflected by the distal end 16. For 
45 fiber 12, a device 24 may be employed to intercept the 
returning light beam 22 and reflect the light beam 22 
downward, as shown in FIG. 2. When the point of attach- 
ment 14 is to be adjacent to both the light source and the 
device for measuring the light beam characteristics, light 
5o measurement is dependent upon reflection of the light beam, 
such as light beam 22, by device 24 as shown for fiber 14. 
The textured surface 16 may be treated so as to contain an 
analyte responsive reagent (not shown in FIG. 1). A chemi- 
luminescent or fluorescent reaction at the textured site 16 
55 resulting from reagent-analyte interactions can be advanta- 
geously utilized wherein a portion of the chemiluminescent 
or fluorescent light enters the fiber 10 or 12, and is trans- 
mitted to a device such as a luminometer, located at one end 
of the fiber 10, or 12, for detection and quantitation. The 
60 textured surfaces 16 may be further described with reference 
to prior art shown in FIG. 3. 
FIG. 3 provides an enlarged view of a cutaway section of 
a fiber 10 having a textured surface 16. The textured surface 
16 is schematically depicted in this case as an array of 
65 cone-shaped projections or pillars 28 defining a cone field 
30, which has been formed within the surface 32 of a fiber 
by removal of portions of surface 32 and subsurface 34 
35 described hereinafter with reference to FIG. 5-8. 
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material. Further details of the textured surface 16 may be 
further described with reference to prior art in FIG. 4. 
FIG. 4 shows a representative cross-section 36 of the cone 
field 30, wherein a deposit 38 of the analyte-responsive 
reagent has been conventionally placed within the crevices 
between cone projections 28. Also shown in FIG. 4 is a 
representation of an erythrocyte 40 (a red blood cell), whose 
size in relationship to the openings between the cones of the 
cone field is large, such that it can typically make no more 
than incidental contact with the outermost projections of the 
cones 28. In a determination of a small analyte, such as 
glucose, the reagent deposit 38 within the cone field 30 is 
readily accessed by the analyte, but protected from the 
erythrocytes 40 based on size selection by the cone field 30 
pattern. Changes in the reagent deposit 38, such as by 
development of a colored complex through reaction with an 
analyte, is advantageously detected by means of a light beam 
(indicated by the arrow 18) being transmitted through the 
matrix of the fiber. The textured surface 16 is generally in the 
form of conical or ridge-like structure microns high and 
wide having a desired aspect ratio (lengthiwide) which is 
preferably greater than one (1). The term “cone field” is 
herein defined to include textures, which are not necessarily 
in the specific shape of cones, but may include various 
linear, box-like or angular arrays of projections so long as 
their aspect ratio is greater than one (1). 
The analytic-responsive reagent 38 placed between the 
crevices of the cones or pillars 28 may be one of many 
analyte-sensing systems. In a manner known in the art, for 
blood glucose determinations, the analyte-sensing system is 
preferably a composition including a peroxidase enzyme and 
color-generating chemical couplers. Many combinations of 
such chemical systems for blood glucose determinations are 
disclosed and described in U.S. Pat. No. 4,935,346, which is 
herein incorporated by reference. For antigens, antibodies, 
enzymes, enzyme inhibitors, and various other biochemical 
agents, attachment of affinity ligands to the textured surface 
16 may be practiced. Herein, the light traveling through the 
fiber is affected by the development of resulting affinity 
complexes on the textured fiber surface 16. Alternatively, 
chemiluminescent or fluorescent techniques may be utilized 
to highlight the affinity attachment of specific biomolecules 
on the textured surface, a portion of the chemiluminescent or 
fluorescent light being captured and transmitted through the 
fiber to a detector. Attachment of ligands to polymeric 
surfaces through covalent binding is well known in the art of 
affinity membranes. 
In a preferred method of use of the invention, a light- 
conducting fiber, such as 10 of FIG. 2, having a textured site 
16 thereon is located at attachment point 14 adjacent to a 
light source for transmittal of a light beam 18 into the fiber 
10, and adjacent also to a device for analysis of light beam 
characteristics of light beam 20 emanating from an opposite 
end of the fiber 10 after it is reflected by the textured site 16. 
In a most preferred embodiment, both light input and 
emanation thereof are at one end of a fiber 10 of predeter- 
mined length, and the textured site 16 is at an opposite end 
of the fiber 16. The textured surface site 16 is first impreg- 
nated with an analyte responsive reagent, such as a plasma 
coated analyte. The textured site 16, is then wetted with a 
fluid, such as by contacting the fiber at this site 16 with a 
small droplet of blood. Interaction of the reagent with the 
analyte, if any, present in the fluid is allowed to occur, 
resulting in an observable physical or chemical change at the 
textured site 16. Light passing through the fiber 10 in the 
region of the textured site 16 is altered in its characteristics 
such as frequency and amplitude, one or more of these 
6 
changes being detectable and preferably quantifiable by the 
device utilized for analysis of light beam 20 emanating from 
the fiber. More particularly, light intercepting the textured 
surface 16 creates a change in the spectral reflectance as a 
5 result of the light interacting with the plasma-coated analyte 
surface 16. 
Thus, as known in the art, a diabetic patient wishing to 
measure his or her blood glucose level would pierce the skin 
of a finger with a lancet whose size and depth of penetration 
10 is designed to provide a minimally sized droplet, to be 
further described hereinafter, of blood at a minimized level 
of associated pain. The patient would preferably then touch 
a textured site 16 to the droplet, the fiber being advanta- 
geously pre-fixed to a measurement device. The patient 
15 would then read and record his or her blood glucose con- 
centration determined upon wetout of the textured surface 
site 16 by the minimally sized blood droplet. The minimally 
sized droplet is to be further described hereinafter. The 
preparation of the textured surface 16 is of particular impor- 
20 tance to the present invention and may be further described 
with reference to FIGS. 5-8. 
One of the main contributions of the present invention is 
to provide ability to the art to make pillars and cones 28 
much closer together than any prior art has been able to 
25 demonstrate. Also, the present invention provides for the use 
of directed hyperthermal beams comprised of oxygen atoms 
or ions to make the aspect ratio high, which gives the art of 
measuring fluid samples a much greater effective surface 
area relative to prior art techniques, in the form of the 
In general, the arrangements shown in FIGS. 5 and 7 
provide one or more processes used to produce closely- 
spaced high aspect-ratio cones or pillars 28, as shown in 
35 FIG. 8, to be further described hereinafter, in optically clear 
polymers consisting of exposing the surfaces of the poly- 
mers to be textured to a directed beam of energetic atomic 
oxygen atoms or ions. The energy of the atomic oxygen 
atoms or ions should be hyperthermal (>1 eV) so as to 
produce the textured surfaces shown in FIG. 8, rather than 
isotropic thermal energy ( ~ 0 . 5  eV), selected by prior art 
methods, that disadvantageously cause directed atomic oxy- 
gen reaction with hydrocarbon atoms that make up the 
polymer of the fiber and disadvantageously produce the 
In the practice of the present invention, it was determined 
that the energy level desired was greater than 1 eV. It was 
further determined that the preferred range was energies in 
the range of 50 to 100 eV. So although it is desired to use 
50 energy levels of greater than 1 eV, the typical range of 
energies used to actually do the texturing, which work best 
in terms of high length-to-width cones 28, is in the 50 eV to 
100 eV range. 
The reactions, provided by the present invention, produce 
55 closely-spaced high aspect-ratio cones or pillars. To perform 
this process one must place the optical polymers to be 
textured in a vacuum system, which evacuated to 5 1 ~ 1 O - ~  
torr. Without the vacuum system atomic and ionic oxygen 
may be attenuated such as that which occurs at high pressure 
60 such as air pressure. An energetic (>1 eV) beam of atomic 
oxygen atoms or ions is then formed in the vacuum system 
by ion or atom beam accelerating devices, such as End Hall 
ion accelerators, electron bombardment ion thrusters or 
other electrostatic, electromagnetic or arc devices, to be 
65 further described hereinafter. These different sources need to 
be able to produce oxygen ion or atom energies of greater 
than 1 eV. 
30 textured surface 16 to receive the fluid samples. 
40 . 
45 prior art surfaces shown in FIG. 1. 
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As known in the art, the resulting beams developed from 
the source of greater than 1 eV are directed hyperthermal 
beams. In one embodiment, the ends of thousand of optical 
fibers can be treated at one time. An arrangement 42 of the 
apparatus for the desired processes is shown in FIG. 5, 
which is devoid, for the sake of clarity, of the desired 
vacuum source, which will be further described hereinafter 
with reference to FIG. 7. 
The arrangement 42 of FIG. 5 comprises a DC power 
supply 44 having a preferred range of 25-150 volts, a 
cathode heater supply 46 connected to a cathode 48, and a 
cooling supply 50 preferably being of water and connected 
to a water cooling coil 52 arranged with a water-cooled 
radiation shield 54. 
The arrangement 42 further comprises a hyperthermal 
atomic oxygen source 56 that can be any source of oxygen 
atoms or ions that produce a directed beam of energy greater 
than 1 eV and shown as beams 58, 60, or 62 and indicated 
as 0, O', O,+ respectively. The ions in the beams 58, 60, and 
62 can be single or multiply charged. The ionic or atomic 
source 56 can be an End Hall source, an electron bombard- 
ment ion source, a DC plasma source, a microwave plasma 
source or any other source provided the source delivers a 
hyperthermal beam of greater than 1 .OV comprised of oxy- 
gen atoms or ions. 
The positive terminal of the DC power supply 44 is 
connected to an anode 66 of the source 56, whereas the 
negative terminal of the DC power supply 44 is connected 
to the cathode 48. The directed hyperthermal beams 58, 60, 
and 62 are preferably directed from one direction onto the 
distal end 16 of each of the light-conducting fibers of the 
bundle 64, so as to produce the textured surface 16 thereon, 
which may be further described with reference to FIG. 6. 
FIG. 6 shows the textured surface as comprising the cones 
28 that are separated from each other by distance no less 
than 1 micron and have an aspect ratio (lengthiwidth) that is 
in the range of from about 1 to about 6. 
The distance between the source 56 and the bundle 64 of 
optical fiber can be varied from 3 cm to 200 cm provided the 
atom or ion beam 58, 60, and 62 does not become depleted 
by scattering, in a manner known in the art, from back- 
ground oxygen gas molecules in a vacuum chamber, to be 
further described hereinafter with reference to FIG. 7. The 
thermal shield 54 is used to prevent sensitive optical fibers, 
such as those comprised in bundle 64, from melting. The 
shield 54 may be a water-cooled shield or may comprise a 
multi-layer insulation or even eliminated if the End Hall 
source 56 uses a hollow cathode 66 and does not produce 
much thermal radiation. For such an arrangement, the opti- 
cal fibers do not need to be relatively close to the End Hall 
source 56, and if the optical fibers are farther away there is 
less cooling needed thereof. 
The bundle 64 is preferably brought together so as to 
provide a hexagonal close-packed array so that the directed 
atomic oxygen or ion beam 58,60, or 62 impinges on the end 
surface of all the fibers, that is the distal end 16 thereof, at 
once so as to produce the textured surface 16 of all of the 
fibers making up the bundle 64. The atomic oxygen source 
56 may cause heating of the optical bundle 64. To prevent 
the heat sensitive polymers, such as polymethylmethacrylat 
from melting, the water cooled or thermal-shield chill 54 is 
inserted between the End Hall cathode 66 and the optical 
fiber bundle 64, as shown in FIG. 5. 
In general, the length of the cones 28 and the spacing 
between the cones 28, can be varied by simply changing the 
fluence (atomic and ionic oxygen exposure level). The 
length and height have been found to grow in proportion to 
8 
the square root of the fluence (known in the art). The vacuum 
source in which the bundle 64 of solid light-conducting 
fibers are placed before being subjected to the hyperthermal 
beams 58,60, or 62, may be further described with reference 
FIG. 7 shows a vacuum source 72 having a door 74 
through which the bundle 64 of fibers may be entered. The 
vacuum source 72 can be any configuration that allows 
evacuation down to a pressure of less than l ~ l O - ~  torr
The vacuum source 72 shows provisions of a roughing 
pump 76 that provides an output to a blower pump 78 which, 
in turn, provides an output source of air to valves 80 and 82, 
all in a manner known in the art. The valve 80 directs its 
l5 output into the vacuum source 72 by way of gate valve 84, 
whereas the valve 82 directs its output into a diffusion pump 
86 (also known in the art). 
The diffusion pump 86 receives heat from a heat supply 
88 by way of elements 90 and 92. The diffusion pump 86 
2o also receives cooling (LN,) by means of a liquid nitrogen 
cooled trap 94. 
The apparatus of FIG. 7, using conventional elements, 
provides for one method of the present invention that causes 
a solid light-conducting fiber used in the analyses of blood 
and to have a desired textured surface 16 by first placing the 
solid light-conducting fibers 10 or 12 having the distal end 
16 in a vacuum source 72 and then subjecting the distal end 
16 to directed hyperthermal beams 58, 60, or 62 comprising 
3o oxygen atoms or ions. The operation of the apparatus of FIG. 
7 provides for textured surface 16, which may be further 
described with reference to FIG. 8. 
FIG. 8 shows a Scanning Electron Microscope image of 
an atomic oxygen textured polymethgylmethacrylate optical 
35 fiber that was textured by the practice of the present inven- 
tion using a hyperthermal (>1 eV) End Hall atomic or ionic 
oxygen source provided by the apparatus of FIG. 7. FIG. 8 
shows that the separation between pillars and cones is 5 1 
micron and extremely thus suitable to prevent the cellular 
4o components of blood from entering the valleys between the 
cones or pillars 28 shown in FIG. 4. In addition, the aspect 
ratio of the fibers is much greater than 1, far better than the 
aspect ratio of less than one (1) achieved by the thermal 
energy atomic oxygen texturing shown in FIG. 1. 
One of the primary advantages of the present invention, 
relating to its minimally invasive feature, is the presence of 
a large surface area in a very small, localized area, by which 
a greatly increased level of analyte-responsive reagent can 
be deposited and maintained. As more fully described in the 
50 previously incorporated by reference '937 patent, the large 
surface area disclosed in the '937 patent allows for the 
accommodation of blood samples preferably in the range of 
1.0 to 2.5 microliters. Based on the practice of the present 
invention, a ratio of 2 to about 6 increase in effective area 
55 relative to the teaching of the '937 patent is achieved which, 
in turn, decreases the amount of blood sample required by a 
factor of 2 to about 6. Thus, the practice of the present 
invention accommodates a blood sample in the range from 
about 0.5 to 1.25 microliters to about from 0.16 to about 
It should now be appreciated that the practice of the 
present invention provides for the use of directed hyperther- 
mal equal or greater than 1 eV beams comprising oxygen 
atoms or ions to produce textured surfaces 16. The present 
65 invention also provides for the thermal radiation shielding to 
prevent overheating of the textured surfaces, while at the 
same time, one embodiment uses an End Hall atomic or 
5 to FIG. 7. 
10 during atomic oxygen operation. 
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ionic oxygen source, having a hollow cathode, and provid- 4. The method according to claim 3, wherein said directed 
ing for texturing optical polymer surfaces without the use of hyperthermal beams is in the range from about 50 eV to 
thermal shielding. about 100 eV. 
The present invention makes use of the natural formation 5. The method of claim 1, wherein said directed hyper- 
of cones or pillars that result in direct hyperthermal (greater 5 thermal beams comprising oxygen ions or atoms are pro- 
than 1 eV) atomic or ionic oxidation of polymers. The vided from a source selected from the group consisting of an 
apparatus of the present invention allows these cones or End Hall source, an electron bombardment ion source, a 
pillars 28 to be sufficiently close or spaced so as to prevent microwave plasma source and an arc source. 
cellular blood components from interfering with optical 6. The method according to claim 5, wherein said selected 
sensing of blood glucose concentration. The present inven- i o  source and said distal end are spaced apart from each other 
tion also provides for small samples of blood to be used as by a distance in the range from about 3 cm to about 200 cm. 
compared to the previous prior art sensors performing the 7. The method according to claim 5, wherein said at least 
same task. one solid light-conducting fiber comprises a plurality 
While the present invention has been described more 
particularly in the context of glucose determinations and 15 8. A method of producing a solid light-conducting fiber 
whole blood by diabetics, the invention may be utilized in 
the determination of other analytes as well, or as even a) placing a plurality of light-conducting fibers arranged 
simultaneous determination of two or more analytes. in a bundle in a vacuum source, each light-conducting 
While the preferred invention is presently contemplated fiber having a point of attachment and a distal end; and 
that has been shown in the drawing as described herein, 20 b) subjecting said distal end to directed hyperthermal 
variations of preferred embodiments will be apparent to beams comprising oxygen ions or atoms, wherein said 
those skilled in the art and the invention should not be directed hyperthermal beams comprising oxygen ions 
construed as limited to the specific forms as shown and or atoms are provided from a source selected from the 
described herein, but rather set forth in the following claims. group consisting of an End Hall source, an electron 
I claim: 25 bombardment ion source, a microwave plasma source 
1. A method of producing a solid light-conducting fiber and an arc source and, wherein said selected source and 
said bundle have a shield interposed therebetween and 
a) placing at least one solid light-conducting fiber with a wherein said selected source and said distal ends of said 
point of attachment and having a distal end in a vacuum bundle are spaced apart from each other by a distance 
source; and in the range from about 3 cm to about 200 cm. 
b) subjecting said distal end to directed hyperthermal 9. The method according to claim 8, wherein said shield 
beams comprising oxygen ions or atoms. is selected from the group consisting of a water-cooled 
2. The method according to claim 1, wherein said vacuum shield and multilayer insulation shield. 
source supplies a pressure of less than about l ~ l O - ~  while 10. The method according to claim 7, wherein said source 
said distal end is being subjected to said directed hyperther- 35 is an End Hall source having a hollow cathode and separated 
mal beams comprising oxygen ions or atoms. from said distal ends of said bundle by a distance in the 
3. The method according to claim 1, wherein said directed range from about 3 cm to about 200 cm. 
hyperthermal beams have an energy level that is in the range 
arranged in a bundle and each having a distal end. 
used in the analysis of a blood comprising the steps of: 
used in the analysis of a blood comprising the steps of: 
30 
from about greater than 1 eV to about 100 eV. * * * * *  
